{"nct_id":"NCT00782184","title":"Ezetimibe/Simvastatin (10 mg/40 mg) vs. the Doubling of Atorvastatin in High Risk Participants (MK-0653A-134 AM1)(COMPLETED)","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2008-11","start_date_type":null,"primary_completion_date":"2010-09","primary_completion_date_type":"ACTUAL","completion_date":"2010-09","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["OGN"]}